SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:uu-432281"
 

Sökning: id:"swepub:oai:DiVA.org:uu-432281" > Metabolomic Profile...

Metabolomic Profile in HFpEF vs HFrEF Patients

Hage, Camilla (författare)
Karolinska Institutet
Löfgren, Lars (författare)
AstraZeneca, Biopharmaceut R&D, Translat Sci & Expt Med, Gothenburg, Sweden.;AstraZeneca, Biopharmaceut R&D, Res & Early Dev Cardiovasc Renal & Metab, Gothenburg, Sweden.
Michopoulos, Filippos (författare)
AstraZenenca, Early Oncol R&D, Biosci, Cambridge, England.
visa fler...
Nilsson, Ralph (författare)
AstraZeneca, Biopharmaceut R&D, Translat Sci & Expt Med, Gothenburg, Sweden.;AstraZeneca, Biopharmaceut R&D, Res & Early Dev Cardiovasc Renal & Metab, Gothenburg, Sweden.
Davidsson, Pia (författare)
AstraZeneca, Biopharmaceut R&D, Translat Sci & Expt Med, Gothenburg, Sweden.;AstraZeneca, Biopharmaceut R&D, Res & Early Dev Cardiovasc Renal & Metab, Gothenburg, Sweden.
Kumar, Chanchal (författare)
AstraZeneca, Biopharmaceut R&D, Translat Sci & Expt Med, Gothenburg, Sweden.;AstraZeneca, Biopharmaceut R&D, Res & Early Dev Cardiovasc Renal & Metab, Gothenburg, Sweden.
Ekström, Mattias (författare)
Karolinska Institutet
Eriksson, Maria J. (författare)
Karolinska Institutet
Lyngå, Patrik (författare)
Karolinska Institutet
Persson, Bengt (författare)
Uppsala universitet,Science for Life Laboratory, SciLifeLab,Beräkningsbiologi och bioinformatik
Wallén, Hakan (författare)
Karolinska Institutet
Gan, Li Ming (författare)
AstraZeneca, Biopharmaceut R&D, Early Clin Dev Res & Early Dev Cardiovasc Renal &, Gothenburg, Sweden.
Persson, Hans (författare)
Karolinska Institutet
Linde, Cecilia (författare)
Karolinska Institutet
visa färre...
Karolinska Institutet AstraZeneca, Biopharmaceut R&D, Translat Sci & Expt Med, Gothenburg, Sweden;AstraZeneca, Biopharmaceut R&D, Res & Early Dev Cardiovasc Renal & Metab, Gothenburg, Sweden. (creator_code:org_t)
Elsevier BV, 2020
2020
Engelska.
Ingår i: Journal of Cardiac Failure. - : Elsevier BV. - 1071-9164 .- 1532-8414. ; 26:12, s. 1050-1059
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Background: Heart failure with preserved ejection fraction (HFpEF) and HF with reduced ejection fraction (HFrEF) are associated with metabolic derangements, which may have different pathophysiological implications.Methods and Results: In new-onset HFpEF (EF of >= 50%, n = 46) and HFrEF (EF of <40%, n = 75) patients, 109 endogenous plasma metabolites including amino acids, phospholipids and acylcarnitines were assessed using targeted metabolomics. Differentially altered metabolites and associations with clinical characteristics were explored. Patients with HFpEF were older, more often female with hypertension, atrial fibrillation, and diabetes compared with patients with HFrEF. Patients with HFpEF displayed higher levels of hydroxyproline and symmetric dimethyl arginine, alanine, cystine, and kynurenine reflecting fibrosis, inflammation and oxidative stress. Serine, cGMP, cAMP, L-carnitine, lysophophatidylcholine (18:2), lactate, and arginine were lower compared with patients with HFrEF. In patients with HFpEF with diabetes, kynurenine was higher (P = .014) and arginine lower (P = .014) vs patients with no diabetes, but did not differ with diabetes status in HFrEF. Decreasing kynurenine was associated with higher eGFR only in HFpEF (P-interaction = .020).Conclusions: Patients with new-onset HFpEF compared with patients with new-onset HFrEF display a different metabolic profile associated with comorbidities, such as diabetes and kidney dysfunction. HFpEF is associated with indices of increased inflammation and oxidative stress, impaired lipid metabolism, increased collagen synthesis, and downregulated nitric oxide signaling. Together, these findings suggest a more predominant systemic microvascular endothelial dysfunction and inflammation linked to increased fibrosis in HFpEF compared with HFrEF.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kardiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)

Nyckelord

Metabolomics
HFpEF
pathophysiology
microvascular dysfunction
inflammation

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy